Table 1.
Expression level of CELF1 in lung carcinoma and relationship to clinicopathological parameters
| Variable | Case no. |
CELF1 expression (RQ: 2
-ΔΔCT
) |
P value | |
|---|---|---|---|---|
| Median | Mean ± SEM | |||
| Gender | ||||
| Male |
41 |
1.1090 |
1.2458 ± 0.9115 |
0.183 |
| Female |
12 |
0.7252 |
0.8938 ± 103.53 |
|
| Age | ||||
| ≤ 60.5 |
32 |
0.9000 |
1.0103 ± 0.8746 |
0.118 |
| > 60.5 |
21 |
0.1164 |
1.4035 ± 1.4948 |
|
| Venous invasion | ||||
| Negative |
40 |
1.0274 |
1.2302 ± 1.2217 |
0.251 |
| Positive |
13 |
0.5492 |
0.9687 ± 0.9781 |
|
| T stage | ||||
| T1 |
7 |
1.5105 |
1.396 ± 1.1033 |
0.041 |
| T2 |
21 |
1.2776 |
1.5178 ± 1.2898 |
|
| T3 |
17 |
0.6242 |
0.8040 ± 0.7079 |
|
| T4 |
8 |
0.3816 |
0.8109 ± 1.4910 |
|
| N stage | ||||
| N0 |
25 |
0.6242 |
0.9983 ± 1.1184 |
0.251 |
| N1 |
11 |
1.3165 |
1.4731 ± 1.4334 |
|
| N2 |
17 |
1.1164 |
1.2142 ± 1.0611 |
|
| Lymph node status | ||||
| N0 |
25 |
0.6242 |
0.9983 ± 1.1184 |
0.164 |
| N1 + N2 |
28 |
1.2321 |
1.3159 ± 1.2020 |
|
| TNM stage | ||||
| Ia |
4 |
1.2109 |
1.4055 ± 1.3481 |
0.089 |
| Ib |
6 |
1.2500 |
1.4397 ± 0.9834 |
|
| IIa |
5 |
1.3322 |
2.1861 ± 1.7131 |
|
| IIb |
13 |
0.6242 |
0.7331 ± 0.5595 |
|
| IIIa |
23 |
0.6624 |
1.1535 ± 1.2526 |
|
| IIIb |
2 |
0.2747 |
0.2747 ± 0.3882 |
|
| Differentiation | ||||
| Well |
6 |
1.0545 |
0.8122 ± 0.5568 |
0.256 |
| Moderate |
28 |
0.9000 |
1.1866 ± 1.1315 |
|
| Poor |
19 |
1.0548 |
1.2476 ± 1.3613 |
|
| Compared case | ||||
| Tumor tissue |
10 |
1.5263 |
1.9005 ± 1.4382 |
0.012 |
| Normal tissue | 10 | 0.2509 | 0.4579 ± 0.4761 | |